The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30
- 1 May 2004
- journal article
- research article
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 13 (2) , 135-144
- https://doi.org/10.1111/j.1365-2354.2003.00435.x
Abstract
The Turkish version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire version 2.0 (EORTC QLQ-C30 v.2.0) has started to be used in clinical trials recently. The objective of the study was to evaluate the validity and reliability of the Turkish version of the EORTC QLQ-C30 v.2.0 and the correlation between the Karnofsky Performance Scale (KPS) and the EORTC QLQ-C30. Two hundred and two lung cancer patients were included in the study between January and March 2000. All the subscales met the minimal standards of reliability (Cronbach's alpha > or = 0.70). Only the role functioning scale differed among the three disease stages of patients (local, locoregional and metastatic). There was no statistically significant difference among therapy types. All interscale correlations were statistically significant (P < 0.01). The strongest correlations were found among the physical functioning, role functioning and fatigue scales. Social functioning was closely related with physical, role, emotional and cognitive functioning. The weakest correlations were between nausea/vomiting and the other scales. Global quality of life (QOL) was substantially correlated with most of the scales except cognitive functioning. The coefficients for the correlation between the items differed between 0.12 and 0.97 and all the subscales were strongly correlated with the scales which they formed. The highest correlation between the EORTC QLQ-C30 and KPS was for physical functioning (r = 0.62, P < 0.05). The Turkish version of the EORTC QLQ-C30 is a valid (by means of interscales validity) and reliable instrument for Turkish lung cancer patients and can be used in clinical studies but needs supporting by the reference data on the QOL of the Turkish population.Keywords
This publication has 26 references indexed in Scilit:
- Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3)European Journal Of Cancer, 1998
- Quality of Life in Patients With Lung CancerChest, 1998
- Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancerQuality of Life Research, 1997
- Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatmentBritish Journal of Cancer, 1995
- The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancerLung Cancer, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of Life During Chemotherapy for Small Cell Lung Cancer: II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact ProfileActa Oncologica, 1992
- Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer PatientsActa Oncologica, 1992
- In vitro culture of human foetal colonic epithelial cells and their transformation with origin minus SV40 DNABritish Journal of Cancer, 1988
- Coefficient alpha and the internal structure of testsPsychometrika, 1951